What financial challenge do cancer patients in Sabah face for essential drugs?

Question

Accepted Answer

Cancer Patients in Sabah Confront Prohibitive Drug Costs

Cancer patients in Sabah face significant financial hurdles in accessing essential medications, with the cost of treatments like immunotherapy drugs often necessitating substantial fundraising efforts. For many, particularly those in rural areas with limited financial means, the price of these life-saving drugs is beyond their reach.
High Cost of Immunotherapy Drugs

The financial burden for cancer patients in Sabah is particularly acute when it comes to advanced treatments such as immunotherapy drugs. One individual mentioned needing to crowdfund a five-figure sum to afford a drug called Perjeta. This highlights the gap between the availability of modern treatments and the ability of patients to pay for them.
Rural Patients Face Greater Disparities

The disparity in financial capacity is more pronounced for cancer patients residing in rural villages within Sabah. These individuals often have fewer financial resources and less access to the networks needed for successful fundraising, making it considerably harder for them to secure the necessary funds for treatment compared to those in urban centres.
Specific Case of RM60,000 Drug Cost

The prohibitive cost is underscored by the case of another cancer patient whose hope lies in a drug that costs RM60,000. This patient's cancer has progressed to stage four, and this expensive medication represents her primary chance for treatment, illustrating the dire financial situations many face in their fight against the disease.

Reading history

Hide →

This history is cleared when the page is closed.

What financial challenge do cancer patients in Sabah face for essential drugs?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends